Additionally, it identified seven genes (BGN, VCAN, FN1, FBLN1, COL4A5, COL1A1, and COL6A3) as shared genes and potential targets for treatment in individuals with both GC and T2D. The gene discussed is COL1A1; the disease is type 2 diabetes mellitus.